An antiviral drug developed in the fight against Ebola has shown promising first signs it could be used to treat coronavirus following a small trial.
Fresh hope for #coronavirus treatment#covid18 #ebolahttps://t.co/Elb5F1SEYx
— Breaking News – News64 (@News64News) April 11, 2020
More than half of a group of severely ill COVID-19 patients improved after receiving Gilead’s experimental drug remdesivir, doctors reported.
However, there is no way to know the odds of the drug’s effectiveness because there was no comparison group in the trial of 53 people.
Read more.
